Herein, we present a CARE checklist-compliant case report documenting an EML4-ALK-fusion-positive lung adenocarcinoma patient with ovarian metastasis who demonstrated significant tumor regression and prolonged survival following lorlatinib treatment. Here, ALK is linked to lung adenocarcinoma.